|
Please click on the following links to read about CBTF funded grants (Unless otherwise noted, most studies are funded for up to two years): Role of TSC2 inactivation in brain development and medulloblastoma, by Dr. Anna Marie Kenney, Memorial Sloan Kettering Cancer Center, New York Molecular Networks of Childhood Diffused Pontine Gliomas, by Javad Nazarian, Ph.D., Center for Genetic Medicine, Children's National Medical Center RAD001 Clinical Trial Summary, by Dr. Mark Kieren, pediatric oncologist, Dana Farber Cancer Institute for the Childhood Brain Tumor Foundation, Germantown, MD |
|
|
|
|